VYGR - Voyager Therapeutics, Inc.
IEX Last Trade
5.675
-0.235 -4.141%
Share volume: 0
Last Updated: Fri 27 Dec 2024 03:30:19 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-1.15%
PREVIOUS CLOSE
CHG
CHG%
$5.91
-0.24
-3.98%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-08 | 2023-03-07 | 2023-05-09 | 2023-08-03 | 2023-11-06 | 2024-02-28 | 2024-05-13 | |
| Total revenue | 712.000 K | 41.086 M | -1.549 M | 150.480 M | 4.853 M | 4.614 M | 90.061 M | 19.516 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 712.000 K | 41.086 M | -1.549 M | 150.480 M | 4.853 M | 4.614 M | 90.061 M | 19.516 M | |
| 5,670.51% | -103.77% | 9,814.65% | -96.77% | -4.92% | 1,851.91% | -78.33% | |||
| Operating expenses | 20.079 M | 26.644 M | 23.013 M | 27.596 M | 30.279 M | 34.121 M | 35.998 M | 35.699 M | |
| Selling general and admin | 7.552 M | 7.307 M | 8.462 M | 9.028 M | 8.294 M | 8.258 M | 10.242 M | 8.607 M | |
| Research and development | 12.527 M | 19.337 M | 14.551 M | 18.568 M | 21.985 M | 25.863 M | 25.756 M | 27.092 M | |
| Total expenses | 20.079 M | 26.644 M | 23.013 M | 27.596 M | 30.279 M | 34.121 M | 35.998 M | 35.699 M | |
| 32.70% | -13.63% | 19.91% | 9.72% | 12.69% | 5.50% | -0.83% | |||
| Operating income | -19.367 M | 14.442 M | -24.562 M | 122.884 M | -25.426 M | -29.507 M | 54.063 M | -16.183 M | |
| Ebit | -19.367 M | 14.442 M | -24.562 M | 122.884 M | -25.426 M | -29.507 M | 54.063 M | -16.183 M | |
| Pretax income | -19.087 M | 17.624 M | -23.610 M | 124.748 M | -22.149 M | -26.078 M | 57.217 M | -11.316 M | |
| -192.34% | -233.97% | -628.37% | -117.75% | 17.74% | -319.41% | -119.78% | |||
| Income tax | 0.000 | 0.000 | 16.000 K | 704.000 K | 59.000 K | -177.000 K | 822.000 K | 14.000 K | |
| Net income basic | -19.087 M | 17.624 M | -23.626 M | 124.044 M | -22.208 M | -25.901 M | 56.395 M | -11.330 M | |
| 192.34% | -234.06% | 625.03% | -117.90% | -16.63% | 317.73% | -120.09% | |||
| Net income | -19.087 M | 17.624 M | -23.626 M | 124.044 M | -22.208 M | -25.901 M | 56.395 M | -11.330 M | |
| 192.34% | -234.06% | 625.03% | -117.90% | -16.63% | 317.73% | -120.09% |